Jonathan W. Simons
145 works · 24,529 citations · h-index 57
Top works
- Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
- Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
- The genomic complexity of primary human prostate cancer
- Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
- Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy
- In vivo molecular and cellular imaging with quantum dots
- Direct Comparison of GAPDH, β-Actin, Cyclophilin, and 28S rRNA as Internal Standards for Quantifying RNA Levels under Hypoxia
- Expression of hypoxia-inducible factor 1? in brain tumors
- Nanotechnology Applications in Cancer
- Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene
- Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
- 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
- Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
- Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
- Tracking the clonal origin of lethal prostate cancer
- Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
- Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
- Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.